A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells.
- 23 July 1996
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 93 (15) , 7933-7937
- https://doi.org/10.1073/pnas.93.15.7933
Abstract
Germ-line missense mutations of the receptor-like tyrosine kinase ret are the causative genetic event of the multiple endocrine neoplasia (MEN) type 2A and type 2B syndromes and of the familial medullary thyroid carcinoma. We have used the rat pheochromocytoma cell line, PC12, as a model system to investigate the mechanism or mechanisms by which expression of activated ret alleles contributes to the neoplastic phenotype in neuroendocrine cells. Here we show that stable expression of ret mutants (MEN2A and MEN2B alleles) in PC12 cells causes a dramatic conversion from a round to a flat morphology, accompanied by the induction of genes belonging to the early as well as the delayed response to nerve growth factor. However, in the transfected PC12 cells, the continuous expression of neuronal specific genes is not associated with the suppression of cell proliferation. Furthermore, expression of ret mutants renders PC12 cells unresponsive to nerve growth factor-induced inhibition of proliferation. These results suggest that induction of an aberrant pattern of differentiation, accompanied by unresponsiveness to growth-inhibitory physiological signals, may be part of the mechanism of action of activated ret alleles in the pathogenesis of neuroendocrine tumors associated with MEN2 syndromes.Keywords
This publication has 32 references indexed in Scilit:
- Catalytic specificity of protein-tyrosine kinases is critical for selective signallingNature, 1995
- Multiple endocrine neoplasia type 2European Journal Of Cancer, 1994
- Oncogenically activated or ligand-stimulatedneukinase stimulates neurite outgrowth in PC12 cellsFEBS Letters, 1994
- Inherited cancers associated with the RET proto-oncogeneCurrent Opinion in Genetics & Development, 1994
- The Wnt-1 proto-oncogene induces changes in morphology, gene expression, and growth factor responsiveness in PC12 cellsNeuron, 1993
- Oncogenes and protein kinases in neuronal growth-factor actionBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1993
- Mutations in the RET proto-oncogene are associated with MEN 2A and FMTCHuman Molecular Genetics, 1993
- Nerve growth factor rapidly regulates VGF gene transcription through cycloheximide sensitive and insensitive pathwaysFEBS Letters, 1992
- ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSKCell, 1992
- Structure, chromosome mapping and regulation of the mouse zinc-finger gene Krox-24; evidence for a common regulatory pathway for immediate-early serum-response genesGene, 1989